journal article·2024-12-31Open access

Optimizing the lyophilization of Lumbricus terrestris erythrocruorin

Sean Dowd, Catherine Sharo, Osheiza Abdulmalik, Jacob Elmer

Abstract

Haemorrhagic shock is a leading cause of death worldwide. Blood transfusions can be used to treat patients suffering severe blood loss but donated red blood cells (RBCs) have several limitations that limit their availability and use. To solve the problems associated with donated RBCs, several acellular haemoglobin-based oxygen carriers (HBOCs) have been developed to restore the most important function of blood: oxygen transport. One promising HBOC is the naturally extracellular haemoglobin (i.e. erythrocruorin) of Lumbricus terrestris (LtEc). The goal of this study was to maximise the portability of LtEc by lyophilising it and then testing its stability at elevated temperatures. To prevent oxidation, several cryoprotectants were screened to determine the optimum formulation for lyophilisation that could minimise oxidation of the haem iron and maximise recovery. Furthermore, samples were also deoxygenated prior to storage to decrease auto-oxidation, while resuspension in a solution containing ascorbic acid was shown to partially reduce LtEc that had oxidised during storage (e.g. from 42% Fe3+ to 11% Fe3+). Analysis of the oxygen equilibria and size of the resuspended LtEc showed that the lyophilisation, storage, and resuspension processes did not affect the oxygen transport properties or the structure of the LtEc, even after 6 months of storage at 40 °C. Altogether, these efforts have yielded a shelf-stable LtEc powder that can be stored for long periods at high temperatures, but future animal studies will be necessary to prove that the resuspended product is a safe and effective oxygen transporter in vivo.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Hemoglobin structure and function · Traumatic Brain Injury and Neurovascular Disturbances · Erythrocyte Function and Pathophysiology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical & Biological Engineering, Villanova University, Villanova, Pennsylvania, USA

Division of Hematology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Funding

National Institutes of Health

References (63)

Show source-provided references
1. 10.1056/NEJMra170564910.1056/NEJMra1705649 ↗
2. Burgess FW, Sborov MJ, Calcagni DR. Hemorrhage, shock, and fluid resuscitation. In: Zajtchuk R, Grande CM, editors. Anesthesia and perioperative care of the combat casualty. 1st ed. Washington, D.C.: Office of the Surgen General at TMM Publications Borden Institute; 1995. p. 81–100.
3. Gurney JM, Le TD, Becker TE, et al. Epidemiology if hemorrhagic shock. In: Pascual JL, Cannon JW, editors. Hemorrhagic shock. 1st ed. New York, NY: Nova Science Publishers, Inc.; 2017. p. 1–17.
4. 10.1111/j.1537-2995.2011.03100.x10.1111/j.1537-2995.2011.03100.x ↗
5. 10.7205/MILMED-D-13-0004710.7205/MILMED-D-13-00047 ↗
6. 10.1111/j.1537-2995.2012.03594.x10.1111/j.1537-2995.2012.03594.x ↗
7. 10.1111/trf.1358010.1111/trf.13580 ↗
8. 10.3109/1073119940911741010.3109/10731199409117410 ↗
9. 10.1016/j.partic.2021.08.01010.1016/j.partic.2021.08.010 ↗
10. 10.3390/jfb301004910.3390/jfb3010049 ↗
11. 10.1080/21691401.2017.129064510.1080/21691401.2017.1290645 ↗
12. 10.1016/j.jchromb.2010.11.02110.1016/j.jchromb.2010.11.021 ↗
13. 10.1016/j.lfs.2012.08.03610.1016/j.lfs.2012.08.036 ↗
14. 10.1111/j.1537-2995.2011.03523.x10.1111/j.1537-2995.2011.03523.x ↗
15. 10.1021/acs.bioconjchem.8b0027110.1021/acs.bioconjchem.8b00271 ↗
16. 10.1016/j.amj.2017.05.00310.1016/j.amj.2017.05.003 ↗
17. 10.1073/pnas.89.3.96710.1073/pnas.89.3.967 ↗
18. 10.1016/j.ijbiomac.2020.11.18810.1016/j.ijbiomac.2020.11.188 ↗
19. 10.1016/s0939-6411(98)00004-610.1016/s0939-6411(98)00004-6 ↗
20. 10.1111/trf.1203810.1111/trf.12038 ↗
21. 10.1006/cryo.1998.207510.1006/cryo.1998.2075 ↗
22. 10.1242/jeb.199.9.207110.1242/jeb.199.9.2071 ↗
23. 10.1152/ajpcell.1984.247.3.C12510.1152/ajpcell.1984.247.3.C125 ↗
24. 10.1146/annurev.bb.03.060174.00201310.1146/annurev.bb.03.060174.002013 ↗
25. 10.1016/0006-3002(53)90005-510.1016/0006-3002(53)90005-5 ↗
26. Zal F, Rousselot M. Annelid haemoglobin lyophilisation process. USA: US Patent & Trademark Office; 2020.
27. Chintala R, Bhambhani A. HPV vaccine formulations comprising aluminum adjuvant and methods of producing same [internet]. US Patent App. 14/126,992. USA: US Patent & Trademark Office; 2020. Available from: http://www.google.com/patents/US20140127260.
28. McAleer WJ, Markus HZ. Lyophilization process for live viral compositions [internet]. USA: US Patent & Trademark Office; 1981. Available from: https://patents.google.com/patent/US4273762A/en.
29. 10.1007/978-1-4615-0549-5_210.1007/978-1-4615-0549-5_2 ↗
30. Patapoff TW, Overcashier DE. The importance of freezing on lyophilization cycle development. BioPharm. 2002;15:16–21 + 72.
31. Zal F, Rousselot M. Annelid haemoglobin lyophilisation process. European Union: European Patent Office; 2018.
32. 10.1371/journal.pone.026399610.1371/journal.pone.0263996 ↗
33. 10.1016/j.pep.2015.09.00610.1016/j.pep.2015.09.006 ↗
34. Timm B, Elmer J. Enhancing the stability of Lumbricus terrestris erythrocruorin (LtEc) for use as a blood substitute. International Symposium for Blood Substitutes 2017 Review; 2019. p. 3093.
35. 10.1081/pdt-5630810.1081/pdt-56308 ↗
36. 10.1002/(SICI)1097-0290(19990420)63:2<166::AID-BIT5>3.0.CO;2-H10.1002/(SICI)1097-0290(19990420)63:2<166::AID-BIT5>3.0.CO;2-H ↗
37. Koike Y, Tomono Y, Tanaka H, et al. The possible effects of the aggregation of the molecules of hemoglobin on its dissociation curves. J Physiol. 1910;40:iv–vii. Available from: https://cir.nii.ac.jp/crid/1571980074887256960.
38. 10.1002/btpr.259310.1002/btpr.2593 ↗
39. 10.1080/21691401.2018.148049110.1080/21691401.2018.1480491 ↗
40. 10.1002/btm2.1006710.1002/btm2.10067 ↗
41. 10.1146/annurev.bi.44.070175.00123310.1146/annurev.bi.44.070175.001233 ↗
42. 10.1016/S0021-9258(19)49732-910.1016/S0021-9258(19)49732-9 ↗
43. Bitensky MW, Yoshida T. Blood storage device and method for oxygen removal. USA: USPTO; 2000.
44. 10.1155/2013/89653710.1155/2013/896537 ↗
45. Panjwani D, Li MLJ. Methemoglobinemi. In: Mattu A, Chanmugam AS, Swadron SP, et al., editors. Avoiding common errors in the emergency department. 2nd ed. Waltham, MA: Wolters Kluwer; 2017. p. 827–829.
46. 10.1016/s0196-0644(99)70167-810.1016/s0196-0644(99)70167-8 ↗
47. 10.1136/jmg.38.5.28510.1136/jmg.38.5.285 ↗
48. Tomoda A Takeshita M Yoneyama Y. Characterization of intermediate hemoglobin produced during methemoglobin reduction by ascorbic acid; 1978.10.1016/S0021-9258(17)34517-9 ↗
49. 10.1080/24734306.2018.146753210.1080/24734306.2018.1467532 ↗
50. Ludlow JT, Wilkerson RG, Nappe TM. Methemoglobinemia. StatPearls. Treasure Island, FL: StatPearls Publishing LLC; 2023.
51. Institute of Medicine F and NB. Vitamin C. In: Institute of Medicine F and NB. editor. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids [internet]. Washington, DC: National Academy Press; 2000. p. 95–186. Available from: https://www.ebsco.com/terms-of-use.
52. Sulaiman S Heis Z Jahangir A. Drug-Nutrient Interactions in the Elderly. In: Malavolta M Mocchegiani E eds. Molecular Basis of Nutrition and Aging. 1st ed. San Diego CA: Academic Press; 2016:73–107.10.1016/B978-0-12-801816-3.00007-8 ↗
53. 10.1016/0300-483x(86)90047-810.1016/0300-483x(86)90047-8 ↗
54. ThermoFisher Scientific. Ascorbic Acid Safety Data Sheet. 2021.
55. Cayman Chemicals. Dehydroascorbic Acid Safety Data Sheet. 2019.
56. 10.1016/B978-1-4377-2786-9.00014-X10.1016/B978-1-4377-2786-9.00014-X ↗
57. 10.1385/1-59259-373-9:03110.1385/1-59259-373-9:031 ↗
58. 10.1002/macp.1986.02187110610.1002/macp.1986.021871106 ↗
59. 10.1111/trf.1281910.1111/trf.12819 ↗
60. Hospira. Mannitol injection for intravenous use [Internet]. 2020. Available from: www.fda.gov/medwatch.
61. Cayman Chemical. Mannitol Safety Data Sheet. 2022.
62. VWR Canada. Sucrose Safety Data Sheet. 2009.
63. 10.1016/j.mvr.2014.07.00510.1016/j.mvr.2014.07.005 ↗